Peter Hovstadius

Peter Hovstadius M.D., Ph.D. is a medical professional with extensive experience in the life sciences sector.4 He is the CEO of Hovstadius Consulting AB, a company that collaborates with Life Science companies and AI/digital startups worldwide.5

Dr. Hovstadius is a specialist in clinical pharmacology with a Ph.D. in drug development from Uppsala University.3 He has over 25 years of experience in the Life Sciences sector, having worked with both large and small companies.4

Throughout his career, Dr. Hovstadius has held several significant positions:

1. Chief Medical Officer (CMO) at Lipum AB, appointed in August 202436
2. Chief Medical Officer (CMO) at XNK Therapeutics, appointed in January 202327
3. Chief Innovation Officer at Novartis
4. Chief Scientific Officer (role details not provided)

Dr. Hovstadius has been actively involved in physician leadership development. He became a member of the American College of Physician Executives in 1999 and has since invested in his own leadership development by attending globally acclaimed leadership courses and obtaining certifications in programs such as 7 Habits of Highly Effective People and Unconscious Bias by Franklin Covey.1

In Sweden, Dr. Hovstadius notes that medical doctors dominate medical director positions in the pharmaceutical industry and have a strong network in the Pharmaceutical Industry Association.1 His experience includes 15 years in pharma leadership positions, which he credits with making him a better leader.1